19-Nordehydroepiandrosterone

19-Nordehydroepiandrosterone
Clinical data
Other names	19-Nor-DHEA; 19-Nor-5-dehydroepiandrosterone; 19-Nor-5-DHEA; Estr-5-en-3β-ol-17-one; 19-Norandrost-5-en-3β-ol-17-one; 3β-Hydroxyestr-5-en-17-one;
Routes of; administration	By mouth
Drug class	Androgen; anabolic steroid; progestogen
Identifiers
	IUPAC name (3S,8R,9S,10R,13S,14S)-3-hydroxy-13-methyl-2,3,4,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one;
CAS Number	17916-75-5;
PubChem CID	53990402;
ChemSpider	277545;
Chemical and physical data
Formula	C18H25O2
Molar mass	274.404 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@]12CC[C@@H]3[C@H]4CC[C@@H](CC4=CC[C@H]3[C@@H]1CCC2=O)O;
	InChI InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h2,12-16,19H,3-10H2,1H3/t12-,13-,14+,15+,16-,18-/m0/s1; Key:KELRVUIFMYCLHB-MTLKIPAASA-N;

19-Nordehydroepiandrosterone (19-nor-DHEA), or 19-nor-5-dehydroepiandrosterone (19-nor-5-DHEA), is an estrane (19-norandrostane) steroid which was never marketed.[1][2] It is the combined derivative of the androgen/anabolic steroid nandrolone (19-nortestosterone) and the androgen prohormone dehydroepiandrosterone (DHEA, or more specifically 5-DHEA).[1][2] Related compounds include 19-nor-5-androstenediol, bolandiol (19-nor-4-androstenediol), and bolandione (nor-4-androstenedione), which are all known orally active prohormones of nandrolone.[2][3][4] 19-Nor-DHEA may occur as a metabolite of bolandione and related steroids.[2]

References

Poortman J, Vroegindewey-Jie D, Thijssen JH, Schwarz F (July 1977). "Relative binding affinity of androstane and C-19-nor-androstane-steroids for the estradiol-receptor in human myometrial and mammary cancer tissue". Mol. Cell. Endocrinol. 8 (1): 27–34. doi:10.1016/0303-7207(77)90015-6. PMID 881104.
Uralets VP, Gillette PA (April 2000). "Over-the-counter Δ⁵ anabolic steroids 5-androsen-3,17-dione; 5-androsten-3β, 17β-diol; dehydroepiandrosterone; and 19-nor-5-androsten-3,17-dione: excretion studies in men". J Anal Toxicol. 24 (3): 188–93. doi:10.1093/jat/24.3.188. PMID 10774538.
Detlef Thieme; Peter Hemmersbach (18 December 2009). Doping in Sports. Springer Science & Business Media. pp. 137–. ISBN 978-3-540-79088-4.
Jehuda Yinon (29 December 2003). Advances in Forensic Applications of Mass Spectrometry. CRC Press. pp. 138–. ISBN 978-0-203-99828-1.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[pmid881104-1] Poortman J, Vroegindewey-Jie D, Thijssen JH, Schwarz F (July 1977). "Relative binding affinity of androstane and C-19-nor-androstane-steroids for the estradiol-receptor in human myometrial and mammary cancer tissue". Mol. Cell. Endocrinol. 8 (1): 27–34. doi:10.1016/0303-7207(77)90015-6. PMID 881104.

[pmid10774538-2] Uralets VP, Gillette PA (April 2000). "Over-the-counter Δ⁵ anabolic steroids 5-androsen-3,17-dione; 5-androsten-3β, 17β-diol; dehydroepiandrosterone; and 19-nor-5-androsten-3,17-dione: excretion studies in men". J Anal Toxicol. 24 (3): 188–93. doi:10.1093/jat/24.3.188. PMID 10774538.

[ThiemeHemmersbach2009-3] Detlef Thieme; Peter Hemmersbach (18 December 2009). Doping in Sports. Springer Science & Business Media. pp. 137–. ISBN 978-3-540-79088-4.

[Yinon2003-4] Jehuda Yinon (29 December 2003). Advances in Forensic Applications of Mass Spectrometry. CRC Press. pp. 138–. ISBN 978-0-203-99828-1.

19-Nordehydroepiandrosterone

See also

References